Analytical evaluation of the Dade Behring Dimension RxL automated N-terminal proBNP (NT-proBNP) method and comparison with the Roche Elecsys 2010

被引：37

作者：

Di Serio, F ^{[1
]}

Ruggieri, V ^{[1
]}

Varraso, L ^{[1
]}

De Sario, R ^{[1
]}

Mastrorilli, A ^{[1
]}

Pansini, N ^{[1
]}

机构：

[1] Policlin Bari, Unita Operat Patol Clin 1, Bari, Italy

来源：

CLINICAL CHEMISTRY AND LABORATORY MEDICINE | 2005年 / 43卷 / 11期

关键词：

brain natriuretic peptide (BNP); heart failure; natriuretic peptides; N-terminal proBNP (NTproBNP);

D O I：

10.1515/CCLM.2005.217

中图分类号：

R446 [实验室诊断]; R-33 [实验医学、医学实验];

学科分类号：

1001 ;

摘要：

Methods to quantify B-type natriuretic peptide (BNP) and N-terminal-propeptide (NT-proBNP) in plasma or serum samples are well established. We assessed the analytical performance of the Dimension RxL NT-proBNP method (Dade-Behring). Evaluation of different sample types was carried out. Controls and heparin plasma pools were used to determine the detection limit, precision, and linearity. Sample stability and the effect of interfering substances on the NT-proBNP concentrations were evaluated. Agreement between Dimension RxL and Elecsys 2010 (Roche Diagnostics) NT-proBNP methods was assessed. The influence of age and sex on NT-proBNP concentrations was evaluated in healthy subjects. Heparin plasma should be the matrix of choice. The detection limit was 2.0 ng/L. The total imprecision was 2.6-3.6% for concentrations from 231 to 9471 ng/L; mean NT-proBNP concentrations of 21 and 15 ng/L were associated with coefficients of variation of 9.9% and 14.7%, respectively. The method was linear up to 32,650 ng/L. There was no effect of temperature, freeze-thaw cycles and interfering substances. A bias was detected when Dimension RxL and Elecsys 2010 NT-proBNP methods were compared. Age and sex were significantly and independently related to N proBNP concentrations. The Dimension RxL NT-proBNP method, like the Elecsys 2010, is suitable for routine use in the diagnosis of heart failure.

引用

页码：1263 / 1273

页数：11

共 38 条

[11] N-terminal pro-brain natriuretic peptide on admission has prognostic value across the whole spectrum of acute coronary syndromes [J].

Galvani, M ;

Ottani, F ;

Oltrona, L ;

Ardissino, D ;

Gensini, GF ;

Maggioni, AP ;

Mannucci, PM ;

Mininni, N ;

Prando, MD ;

Tubaro, M ;

Vernocchi, A ;

Vecchio, C .

CIRCULATION, 2004, 110 (02) :128-134

[12]

HOBBS FD, 2004, EUR HEART J, V21, P1877

[13] ACC/AHA guidelines for the evaluation and management of chronic heart failure in the adult: Executive summary - A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to revise the 1995 Guidelines for the evaluation and management of heart failure) [J].

Hunt, SA ;

Baker, DW ;

Chin, MH ;

Cinquegrani, MP ;

Feldman, AM ;

Francis, GS ;

Ganiats, TG ;

Goldstein, S ;

Gregoratos, G ;

Jessup, ML ;

Noble, RJ ;

Packer, M ;

Silver, MA ;

Stevenson, LW ;

Gibbons, RJ ;

Antman, EM ;

Alpert, JS ;

Faxon, DP ;

Fuster, V ;

Gregoratos, G ;

Jacobs, AK ;

Hiratzka, LF ;

Russell, RO ;

Smith, SC .

CIRCULATION, 2001, 104 (24) :2996-3007

[14] Natriuretic peptides in unstable coronary artery disease [J].

Jernberg, T ;

James, S ;

Lindahl, B ;

Johnston, N ;

Stridsberg, M ;

Venge, P ;

Wallentin, L .

EUROPEAN HEART JOURNAL, 2004, 25 (17) :1486-1493

[15] Brain natriuretic peptide and N-terminal brain natriuretic peptide in the diagnosis of heart failure in patients with acute shortness of breath [J].

Lainchbury, JG ;

Campbell, E ;

Frampton, CM ;

Yandle, TG ;

Nicholls, MG ;

Richards, AM .

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2003, 42 (04) :728-735

[16] The impact of cardiac natriuretic peptide determination on the diagnosis and management of heart failure [J].

Mair, J ;

Hammerer-Lercher, A ;

Puschendorf, B .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2001, 39 (07) :571-588

[17] Biochemical detection of left-ventricular systolic dysfunction [J].

McDonagh, TA ;

Robb, SD ;

Murdoch, DR ;

Morton, JJ ;

Ford, I ;

Morrison, CE ;

Tunstall-Pedoe, H ;

McMurray, JJV ;

Dargie, HJ .

LANCET, 1998, 351 (9095) :9-13

[18]

Mueller C, 2005, CLIN LAB, V51, P1

[19] Long-term stability of endogenous B-type natriuretic peptide (BNP) and amino terminal proBNP (NTproBNP) in frozen plasma samples [J].

Mueller, T ;

Gegenhuber, A ;

Dieplinger, B ;

Poelz, W ;

Haltmayer, M .

CLINICAL CHEMISTRY AND LABORATORY MEDICINE, 2004, 42 (08) :942-944

[20] Interpretation of plasma brain natriuretic peptide concentrations may require adjustment for patient's age [J].

Nageh, T ;

Chin, D ;

Cooke, JC ;

Meehan, N ;

Monaghan, MJ ;

Sherwood, RA .

ANNALS OF CLINICAL BIOCHEMISTRY, 2002, 39 :151-153

← 1 2 3 4 →